Tag: Sun Pharma

spot_img

Tildrakizumab for Treatment of Moderate-to-Severe Plaque Psoriasis: Could Sun Pharma’s ‘Ilumya’ be a Better Option?

Tildrakizumab is being marketed by Sun Pharma under the trade name Ilumya, and has been approved by FDA in March 2018 after analysis of...

Sun Pharma Presents Data, Offering Insights for Treating People with or at Risk of Skin Cancer

Sun Pharma has presented data on ODOMZO® (drug for treatment of skin cancer) and LEVULAN® KERASTICK® + BLU-U®, (for treating precancerous lesions) supporting safety...

Stay in touch:

87,846FansLike
45,152FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...